Advertisement

Scope and Distribution of the RA Problem

  • Alan Ebringer
Chapter

Abstract

Rheumatoid arthritis is a multi-system disorder characterised by chronic destructive synovitis attacking initially the small joints of the hands and feet but eventually producing generalised severe morbidity and an increased mortality.

There are over 20 million people in the world who suffer from this incapacitating disease, but the number of affected individuals may be higher if early stages or ‘formes frustes’ are included.

Keywords

Rheumatoid Arthritis Rheumatoid Arthritis Patient Rheumatic Fever Molecular Mimicry Small Joint 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Aho K, Koskenvuo M, Tuominen J, Kaprio J. Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol. 1986;13:899–902.PubMedGoogle Scholar
  2. Aletaha D, Funovits J, Smolen JS. Physical disability in rheumatoid arthritis is associated with cartilage damage rather than bone destruction. Ann Rheum Dis. 2011;70:733–9.PubMedCrossRefGoogle Scholar
  3. Badley EM, Tennant A. Impact of disablement due to rheumatic disorders in a British population: estimates of severity and prevalence from the Calderdale Rheumatic Disablement Survey. Ann Rheum Dis. 1993;52:6–13.PubMedCrossRefGoogle Scholar
  4. Brennan FM, Maini RN, Feldmann M. TNF-α – a pivotal role in rheumatoid arthritis? Br J Rheumatol. 1992;31:293–8.PubMedCrossRefGoogle Scholar
  5. Ebringer A, Rashid T, Wilson C. Molecular mimicry as the basis of new theory of autoimmunity. In: Zouali M, editor. Frontiers in autoimmunity. Amsterdam/Washington, DC: IOS Press; 2003. p. 79–99.Google Scholar
  6. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of prevalence of arthritis and other rheumatic conditions in the United States. Arthritis Rheum. 2008;58:15–25.PubMedCrossRefGoogle Scholar
  7. Klareskog L, Padyukov L, Alfredsson L. Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol. 2007;A19:49–54.PubMedCrossRefGoogle Scholar
  8. Lajas C, Abasolo L, Belladel B, Hernadez-Garcia C, Carmona L, Vargas E, et al. Costs and predictors of costs in rheumatoid arthritis: a prevalence based study. Arthritis Rheum. 2003;49:64–70.PubMedCrossRefGoogle Scholar
  9. McIntosh E. The costs of rheumatoid arthritis. Br J Rheumatol. 1996;35:781–90.PubMedCrossRefGoogle Scholar
  10. Schiff B, Mizrachi Y, Orgad S, Yaron M, Gazit E. Association of HLA-Aw 31 and HLA-DR1 with adult rheumatoid arthritis. Ann Rheum Dis. 1982;41:403–4.PubMedCrossRefGoogle Scholar
  11. Silman AJ, MacGregor AJ, Thomson W, Holligan S, Carthy D, Farhan A, et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol. 1993;32:903–7.PubMedCrossRefGoogle Scholar
  12. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. New Engl J Med. 1978;298:869–71.PubMedCrossRefGoogle Scholar
  13. Stastny P, Ball EJ, Khan MA, Olsen NJ, Pincus T, Gao X. HLA-DR4 and other genetic markers in rheumatoid arthritis. Br J Rheumatol. 1988;27(Suppl II):132–8.PubMedGoogle Scholar
  14. Svendsen AJ, Holm NV, Kyvik K, Petersen PH, Junker P. Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population. Br Med J. 2002;324:264–6.CrossRefGoogle Scholar
  15. Yelin EK. The cost of rheumatoid arthritis; absolute, incremental and marginal estimates. J Rheumatol. 1996;23:47–51.Google Scholar
  16. Ziff M, Cavender D, Haskard D. Pathogenetic factors in rheumatoid synovitis. Br J Rheumatol. 1988;27(Suppl II):153–6.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  • Alan Ebringer
    • 1
  1. 1.King’s College London Division of Life SciencesUCH School of MedicineLondonUK

Personalised recommendations